Biological correlates of clinical subgroups of Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 14, Issue 3-4, 2002, Pages 191-197

  Sjögren, Magnus ^a   Wikkelsö, Carsten ^a   Östling, Svante ^a   Wallin, Anders ^a   Blennow, Kaj ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

5 HIAA; Alzheimer's disease; Frontotemporal dementia; HMPG; Homovanillic acid; Monoamine metabolites; Regional cerebral blood flow; Single photon emission computerized tomography

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; APOLIPOPROTEIN E; HOMOVANILLIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN REGION; CEREBROSPINAL FLUID LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PHENOMENOLOGY; PRIORITY JOURNAL; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; BRAIN; FEMALE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; PARIETAL LOBE; PSYCHIATRIC STATUS RATING SCALES; PTEROYLPOLYGLUTAMIC ACIDS; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036970189     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066025     Document Type: Article

References (40)

1. Blennow K, Wallin A: Clinical heterogeneity of probable Alzheimer's disease. J Geriatr Psychiatry Neurol 1992;5:106-113.
2. Blennow K, Wallin A, Gottfries C-G: Presence of parieto-temporal symptomatology distinguishing early and late onset Alzheimer's disease. Int J Geriatr Psychiatry 1991;6:147-154.
3. Gottfries CG: Neurochemical aspects on aging and diseases with cognitive impairment. J Neurosci Res 1990;27:541-547.
4. Hardy J, Adolfsson R, Alafuzoff I, Bucht G, Marcusson J, Nyberg P, Perdahl E, Wester P, Winblad B: Transmitter deficits in Alzheimer's diesase. Neurochem Int 1985;7:545-563.
5. Palmer AM, DeKosky ST: Monoamine neurons in aging and Alzheimer's disease. J Neural Transm Gen Sect 1993;91:135-159.
6. Blennow K, Wallin A, Gottfries C-G, Lekman A, Karlsson I, Skoog I, Svennerholm L: Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease. Neurobiol Aging 1992;13:107-113.
7. Brane G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A: Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia. Alzheimer Dis Assoc Disord 1989;3:148-156.
8. Kawakatsu S, Morinobu S, Shinohara M, Totsuka S, Kobashi K: Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease. Biol Psychiatry 1990;28:387-400.
9. Martignoni E, Bono G, Blandini F, Sinforiani E, Merlo P, Nappi G: Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl. J Neural Transm Park Dis Dement Sect 1991;3:15-25.
10. Parnetti L, Gaiti A, Reboldi GP, Santucci C, Mecocci P, Brunetti M, Cadini D, Senin U: CSF monoamine metabolites in old age dementias. Mol Chem Neuropathol 1992;16:143-157.
11. Sjögren M, Minthon L, Passant U, Wallin A, Blennow K: Decreased monoamine metabolites in frontotemporal dementia and Alzheimer disease. Neurobiology of Aging 1998;19:379-384.
12. Francis PT, Holmes C, Webster M-T, Stratmann GC, Procter AW, Bowen DM: Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. Dementia 1993;4:172-177.
13. Sparks DL, Markesbery WR: Altered serotonergic and cholinergic synaptic markers in Pick's disease. Arch Neurol 1991;48:796-799.
14. Burns A, Philpot MP, Costa DC, Ell PJ, Levy R: The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry 1989;52:248-253.
15. Masterman DL, Mendez MF, Fairbanks LA, Cummings JL: Sensitivity, specificity, and positive predictive value of technetium-99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias. J Geriatr Psychiatry Neurol 1997;10:15-21.
16. 99mTc-HMPAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987;50:1101-1109.
17. Eberling JL, Jagust WJ, Reed BR, Baker MG: Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging 1992;13:483-491.
18. Read SL, Miller BL, Mena I, Kim R, Itabashi H, Darby A: SPECT in dementia: Clinical and pathological correlation. J Am Geriatr Soc 1995;43:1243-1247.
19. Sjögren M, Gustafson L, Wikkelso C, Wallin A: Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio. Dementia Geriatr Cogn Disord 2000;11:275-285.
20. 99mTc]-d,l-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 1994;57:285-295.
21. Miller BL, Gearhart R: Neuroimaging in the diagnosis of frontotemporal dementia. Dement Geriatr Cogn Disord 1999;10:71-74.
22. Kobari M, Fukuuchi Y, Shinohara T, Obara K, Nogawa S: Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders. J Neurol Sci 1995;128:212-218.
23. Aiba I, Indo T, Takahashi A: The effects of dopamine on regional cerebral blood flow in patients with Parkinson's disease before and after L-dopa measurement by Xe-enhanced CT. Rinsho Shinkeigaku 1994;34:1099-1104.
24. Kroppenstedt SN, Stover JF, Unterberg AW: Effects of dopamine on posttraumatic cerebral blood flow, brain edema, and cerebrospinal fluid glutamate and hypoxanthine concentrations. Crit Care Med 2000;28:3792-3798.
25. McCulloch J, Deshmukh VD, Harper AM: Indirect sympathomimetic agents and cerebral blood flow and metabolism. Eur J Pharmacol 1978;47:11-18.
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report on the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-944.
27. Wallin A, Blennow K, Scheltens P: Research criteria for clinical diagnosis of 'pure' Alzheimer's disease. Drugs Today 1994;30:265-273.
28. Wallin A, Edman Å, Blennow K, Gottfries C-G, Karlsson I, Regland B, Sjögren M: Stepwise comparative status analysis (STEP): A tool for identification of regional brain syndromes in dementia. J Geriatr Psychiatry Neurol 1996;9:185-199.
29. Brun A, Englund B, Gustafsson L, Passant U, Mann DMA, Neary D, Snowden JS: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
30. Sjögren M, Edman Å, Wallin A: Symptomatological characteristics distinguish between frontotemporal dementia and vascular dementia with a dominant frontal lobe syndrome. Int J Geriatr Psychiatry 1997;12:656-661.
31. Folstein M, Folstein S, McHugh P: 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
32. Sorensen JA: Methods for Quantitating Radioactivity in vivo by External Counting Measurements. Madison, University of Wisconsin, 1971.
33. Larsson SA: Gamma camera emission tomography. Development and properties of a multisectional emission computed tomography system. Acta Radiol Suppl 1980;363:1-75.
34. 99mTc-HMPAO SPECT. Nucl Med Commun 1994;15:814-823.
35. Parnetti L, Gottfries J, Karlsson I, Långström G, Gottfries C-G, Svennerholm L: Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatographymass spectrometry. Acta Psychiatr Scand 1987;75:542-548.
36. Blennow K, Wallin A, Gottfries CG, Karlsson I, Mansson JE, Skoog I, Wikkelso C, Svennerholm L: Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age. Eur Neuropsychopharmacol 1993;3:55-61.
37. Kane JW, Gowland E: A method for the identification of apolipoprotein E isoforms employing chemical precipitation and flat bed isoelectric focusing in agarose. Ann Clin Biochem 1986;23:509-513.
38. Skoog I, Vanmechelen E, Andreasson LA, Palmertz B, Davidsson P, Hesse C, Blennow K: A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year olds: Relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration 1995;4:433-442.
39. Starkstein SE, Migliorelli R, Teson A, Sabe L, Vazquez S, Turjanski M, Robinson RG, Leiguarda R: Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. J Neurol Neurosurg Psychiatry 1994;57:790-796.
40. Risberg J: Frontal lobe degeneration of non-Alzheimer type. 3. Regional cerebral blood flow. Arch Gerontol Geriatr 1987;6:225-233.